← Evidence map

ReviewFrontiers in pharmacology2024

Isoliquiritigenin as a modulator of the Nrf2 signaling pathway: potential therapeutic implications.

Mangmang Qiu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

6 papers cite it

2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 39444605